These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31670596)
21. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact. Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210 [TBL] [Abstract][Full Text] [Related]
22. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings. Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328 [TBL] [Abstract][Full Text] [Related]
23. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy. Park KJ; Kim MH; Kim JK Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959 [TBL] [Abstract][Full Text] [Related]
24. Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy. Lim CS; McInnes MDF; Flood TA; Breau RH; Morash C; Thornhill RE; Schieda N AJR Am J Roentgenol; 2017 May; 208(5):1037-1044. PubMed ID: 28267359 [TBL] [Abstract][Full Text] [Related]
25. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde H; Stomps S; Schoots IG; Biesma DH; Witjes JA; van Basten JA Eur Urol Oncol; 2022 Jun; 5(3):328-337. PubMed ID: 32972895 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer. Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981 [TBL] [Abstract][Full Text] [Related]
27. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer. Martini A; Soeterik TFW; Haverdings H; Rahota RG; Checcucci E; De Cillis S; Hermanns T; Fankhauser CD; Afferi L; Moschini M; Mattei A; Kesch C; Heidegger I; Preisser F; Zattoni F; Marquis A; Marra G; Gontero P; Briganti A; Montorsi F; Porpiglia F; Van Basten JP; Van den Bergh RCN; Van Melick HHE; Ploussard G; Gandaglia G; Valerio M J Urol; 2022 Feb; 207(2):350-357. PubMed ID: 34547922 [TBL] [Abstract][Full Text] [Related]
28. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling. Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer. Demirtaş A; Sönmez G; Tombul ŞT; Demirtaş T; Akgün H Urol Int; 2019; 103(3):256-261. PubMed ID: 31242496 [TBL] [Abstract][Full Text] [Related]
30. Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates. Luzzago S; Piccinelli ML; Mistretta FA; Bianchi R; Cozzi G; Di Trapani E; Cioffi A; Catellani M; Fontana M; Jannello LMI; Botticelli FMG; Marvaso G; Alessi S; Pricolo P; Ferro M; Matei DV; Jereczek-Fossa BA; Fusco N; Petralia G; de Cobelli O; Musi G BJU Int; 2022 Apr; 129(4):524-533. PubMed ID: 34687137 [TBL] [Abstract][Full Text] [Related]
31. A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient. Rud E; Diep L; Baco E World J Urol; 2018 Apr; 36(4):629-637. PubMed ID: 29349572 [TBL] [Abstract][Full Text] [Related]
32. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study. Ucar T; Gunduz N; Demirci E; Culpan M; Gunel H; Kir G; Atis RG; Yildirim A Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579 [TBL] [Abstract][Full Text] [Related]
33. Extraprostatic extension in prostate cancer: primer for radiologists. Shieh AC; Guler E; Ojili V; Paspulati RM; Elliott R; Ramaiya NH; Tirumani SH Abdom Radiol (NY); 2020 Dec; 45(12):4040-4051. PubMed ID: 32390076 [TBL] [Abstract][Full Text] [Related]
34. The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade. Hennes DMZB; Sewell J; Kerger M; Hovens CM; Peters JS; Costello AJ; Ryan A; Corcoran NM BJU Int; 2021 Dec; 128 Suppl 3():45-51. PubMed ID: 34310033 [TBL] [Abstract][Full Text] [Related]
35. Combining the Tumor Contact Length and Apparent Diffusion Coefficient Better Predicts Extraprostatic Extension of Prostate Cancer with Capsular Abutment: A 3 Tesla MR Imaging Study. Ito K; Chiba E; Oyama-Manabe N; Washino S; Manabe O; Miyagawa T; Hamamoto K; Hiruta M; Tanno K; Shinmoto H Magn Reson Med Sci; 2022 Jul; 21(3):477-484. PubMed ID: 33994494 [TBL] [Abstract][Full Text] [Related]
36. The absolute tumor-capsule contact length in the diagnosis of extraprostatic extension of prostate cancer. Eurboonyanun K; Pisuchpen N; O'Shea A; Lahoud RM; Atre ID; Harisinghani M Abdom Radiol (NY); 2021 Aug; 46(8):4014-4024. PubMed ID: 33770224 [TBL] [Abstract][Full Text] [Related]
37. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol. Luzzago S; Musi G; Catellani M; Russo A; Di Trapani E; Mistretta FA; Bianchi R; Cozzi G; Conti A; Pricolo P; Ferro M; Matei DV; Mirone V; Petralia G; de Cobelli O Urol Int; 2018; 101(1):56-64. PubMed ID: 29734177 [TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue. Jabbour T; Peltier A; Rocq L; Sirtaine N; Lefebvre Y; Bourgeno H; Baudewyns A; Roumeguère T; Diamand R BJU Int; 2024 Apr; 133(4):432-441. PubMed ID: 37943114 [TBL] [Abstract][Full Text] [Related]
39. Automated Detection and Grading of Extraprostatic Extension of Prostate Cancer at MRI via Cascaded Deep Learning and Random Forest Classification. Simon BD; Merriman KM; Harmon SA; Tetreault J; Yilmaz EC; Blake Z; Merino MJ; An JY; Marko J; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B Acad Radiol; 2024 Oct; 31(10):4096-4106. PubMed ID: 38670874 [TBL] [Abstract][Full Text] [Related]
40. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer. Anderson BB; Oberlin DT; Razmaria AA; Choy B; Zagaja GP; Shalhav AL; Meeks JJ; Yang XJ; Paner GP; Eggener SE Eur Urol; 2017 Sep; 72(3):455-460. PubMed ID: 27986368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]